APA (7th ed.) Citation

S, T., E, H., LT, G. M., S, F., ÅK, Ö., RJ, F., . . . VD, H. (2026). Dual-time-point [18F]FDG-PET/CT as a prognostic biomarker in patients with pleural mesothelioma undergoing immunotherapy. EJNMMI research. https://doi.org/10.1186/s13550-026-01469-x

Chicago Style (17th ed.) Citation

S, Thunold, et al. "Dual-time-point [18F]FDG-PET/CT as a Prognostic Biomarker in Patients with Pleural Mesothelioma Undergoing Immunotherapy." EJNMMI Research 2026. https://doi.org/10.1186/s13550-026-01469-x.

MLA (9th ed.) Citation

S, Thunold, et al. "Dual-time-point [18F]FDG-PET/CT as a Prognostic Biomarker in Patients with Pleural Mesothelioma Undergoing Immunotherapy." EJNMMI Research, 2026, https://doi.org/10.1186/s13550-026-01469-x.